ID   BNI-FNS-51
AC   CVCL_C0X2
DR   GEO; GSM5460964
DR   Wikidata; Q114310759
RX   PubMed=35394061;
CC   Population: Chinese.
CC   Characteristics: Established from the PDX-NF2-FNS-05 xenograft.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral nervous system, cranial nerve, facial nerve; UBERON=UBERON_0001647.
CC   Cell type: Schwann cell; CL=CL_0002573.
ST   Source(s): PubMed=35394061
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D12S391: 18,20
ST   D13S317: 9,10
ST   D16S539: 11
ST   D18S51: 13,16
ST   D19S433: 13,14
ST   D1S1656: 15
ST   D21S11: 29,30
ST   D2S1338: 20,25
ST   D3S1358: 16,17
ST   D5S818: 10,13
ST   D6S1043: 11,14
ST   D7S820: 12
ST   D8S1179: 10,14
ST   FGA: 19,23
ST   Penta D: 11,15
ST   Penta E: 12,14
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3274; Neurofibromatosis type 2
DI   NCIt; C188213; Facial nerve schwannoma
DI   ORDO; Orphanet_637; Neurofibromatosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
RX   PubMed=35394061; DOI=10.1002/path.5908;
RA   Zhao F., Chen Y., Li S.-W., Zhang J., Zhang S., Zhao X.-B., Yang Z.-J.,
RA   Wang B., He Q.-Y., Wang L.-M., Xu L., Liu P.-N.;
RT   "Novel patient-derived xenograft and cell line models for therapeutic
RT   screening in NF2-associated schwannoma.";
RL   J. Pathol. 257:620-634(2022).
//